CALC.NASDAQCalcimedica, INC

Form 4: CalciMedica Officer Michael J. Dunn Reports Stock Option Exercise

Sentiment:

SEC Form 4 Filing

📋All filings for Calcimedica, INC
🔒Login to Follow

Michael J. Dunn, President and COO of CalciMedica, Inc., exercised stock options to acquire 11,761 shares of common stock at $1.39 per share.

Summary

  • On September 9, 2024, Michael J. Dunn, President and COO of CalciMedica, Inc., exercised stock options.
  • He acquired 11,761 shares of common stock at a price of $1.39 per share.
  • These options were received in exchange for stock options of the original CalciMedica, Inc. due to a merger with Graybug Vision, Inc.
  • The merger occurred on March 20, 2023, where Graybug Vision acquired CalciMedica, and subsequently changed its name to CalciMedica, Inc.

Sentiment

Score: 5

Explanation: This is a routine Form 4 filing, indicating an officer exercised stock options. It doesn't inherently suggest positive or negative sentiment, but rather reflects a standard transaction.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.

Stakeholder Impact

  • The transaction increases the number of outstanding shares, potentially diluting existing shareholders' ownership.

Key Dates

DateDescription
March 20, 2023Merger of Graybug Vision and CalciMedica; Graybug Vision renamed CalciMedica, Inc.
September 9, 2024Michael J. Dunn exercised stock options to acquire 11,761 shares.
September 11, 2024Date of Form 4 filing.
October 1, 2024Employee Stock Option (Right to Buy) exercisable

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.